Angioimmunoblastic T-cell lymphoma

Critical Reviews in Oncology/Hematology

Volumn 68, Issue 3, 2008, Pages 264-271

  Iannitto, Emilio ^a   Ferreri, Andrés J M ^b   Minardi, Viviana ^a   Tripodo, Claudio ^c   Kreipe, Hans H ^d  

^a UNIVERSITY OF PALERMO   (Italy)

^b Medical Oncology Unit   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

^d HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Angioimmunoblastic lymphoma; Autologous transplant; Hypergammaglobulinemia; Non Hodgkin lymphoma; Peripheral T cell lymphoma

Indexed keywords

ALEMTUZUMAB; CLADRIBINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DOXORUBICIN; FLUDARABINE; INTERFERON; METHOTREXATE; PREDNISONE; THALIDOMIDE; VINCRISTINE;

ANGIOIMMUNOBLASTIC T CELL LYMPHOMA; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER STAGING; CLINICAL FEATURE; CLINICAL TRIAL; HUMAN; IMMUNOPHENOTYPING; LOW DRUG DOSE; LYMPH NODE BIOPSY; MORPHOLOGY; OVERALL SURVIVAL; PROGNOSIS; REVIEW; RISK FACTOR; T CELL LYMPHOMA; TREATMENT RESPONSE;

B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; DENDRITIC CELLS; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPH NODES; LYMPHOMA, T-CELL; MALE; NEPRILYSIN; STEM CELL TRANSPLANTATION; SURVIVAL RATE; THALIDOMIDE; TRANSPLANTATION, AUTOLOGOUS;

EID: 54349091049     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2008.06.012     Document Type: Review

References (57)

1. Jaffe E.S., Harris N.L., Stein H., and Vardiman J.W. Tumours of haematopoietic and lymphoid tissue. In: Jaffe E.S., Harris N.L., Stein H., and Vardiman J.W. (Eds). Pathology & genetics (2001), IRAC Press, Lyon 135-137
2. Grogg K.L., Attygalle A.D., Macon W.R., et al. Angioimmunoblastic T-cell lymphoma: a neoplasm of germinal-center T-helper cells?. Blood 106 (2005) 1501-1502
3. Freter C.E., and Cossman J. Angioimmunoblastic lymphadenopathy with dysproteinemia. Semin Oncol 20 (1993) 627-635
4. Weiss L.M., Jaffe E.S., Liu X.F., et al. Detection and localization of Epstein-Barr viral genomes in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. Blood 79 (1992) 1789-1795
5. Brauninger A., Spieker T., Willenbrock K., et al. Survival and clonal expansion of mutating "forbidden" (immunoglobulin receptor-deficient) Epstein-Barr virus-infected b cells in angioimmunoblastic t cell lymphoma. J Exp Med 194 (2001) 927-940
6. Luppi M., and Torelli G. The new lymphotropic herpesviruses (HHV-6, HHV-7, HHV-8) and hepatitis C virus (HCV) in human lymphoproliferative diseases: an overview. Haematologica 81 (1996) 265-281
7. Suchi T., Lennert K., Tu L.Y., et al. Histopathology and immunohistochemistry of peripheral T cell lymphomas: a proposal for their classification. J Clin Pathol 40 (1987) 995-1015
8. Patsouris E., Noel H., and Lennert K. Angioimmunoblastic lymphadenopathy-type of T-cell lymphoma with a high content of epithelioid cells. Histopathology and comparison with lymphoepithelioid cell lymphoma. Am J Surg Pathol 13 (1989) 262-275
9. Feller A.C., Griesser H., Schilling C.V., et al. Clonal gene rearrangement patterns correlate with immunophenotype and clinical parameters in patients with angioimmunoblastic lymphadenopathy. Am J Pathol 133 (1988) 549-556
10. Dogan A., Attygalle A.D., and Kyriakou C. Angioimmunoblastic T-cell lymphoma. Br J Haematol 121 (2003) 681-691
11. Attygalle A., Al Jehani R., Diss T.C., et al. Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10. Blood 99 (2002) 627-633
12. Kim C.H., Lim H.W., Kim J.R., et al. Unique gene expression program of human germinal center T helper cells. Blood 104 (2004) 1952-1960
13. Tsuchiya T., Ohshima K., Karube K., et al. Th1, Th2, and activated T-cell marker and clinical prognosis in peripheral T-cell lymphoma, unspecified: comparison with AILD, ALCL, lymphoblastic lymphoma, and ATLL. Blood 103 (2004) 236-241
14. Attygalle A.D., Diss T.C., Munson P., et al. CD10 expression in extranodal dissemination of angioimmunoblastic T-cell lymphoma. Am J Surg Pathol 28 (2004) 54-61
15. Went P., Agostinelli C., Gallamini A., et al. Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score. J Clin Oncol 24 (2006) 2472-2479
16. Dupuis J., Boye K., Martin N., et al. Expression of CXCL13 by neoplastic cells in angioimmunoblastic T-cell lymphoma (AITL): a new diagnostic marker providing evidence that AITL derives from follicular helper T cells. Am J Surg Pathol 30 (2006) 490-494
17. Roncador G., Garcia Verdes-Montenegro J.F., Tedoldi S., et al. Expression of two markers of germinal center T cells (SAP and PD-1) in angioimmunoblastic T-cell lymphoma. Haematologica 92 (2007) 1059-1066
18. Weiss L.M., Strickler J.G., Dorfman R.F., et al. Clonal T-cell populations in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. Am J Pathol 122 (1986) 392-397
19. Lome-Maldonado C., Canioni D., Hermine O., et al. Angio-immunoblastic T cell lymphoma (AILD-TL) rich in large B cells and associated with Epstein-Barr virus infection. A different subtype of AILD-TL?. Leukemia 16 (2002) 2134-2141
20. Rodig S.J., Abramson J.S., Pinkus G.S., et al. Heterogeneous CD52 expression among hematologic neoplasms: implications for the use of alemtuzumab (CAMPATH-1H). Clin Cancer Res 12 (2006) 7174-7179
21. Chang S.T., Lu C.L., and Chuang S.S. CD52 expression in non-mycotic T- and NK/T-cell lymphomas. Leuk Lymphoma 48 (2007) 117-121
22. Piccaluga P.P., Agostinelli C., Righi S., Zinzani P.L., and Pileri S.A. Expression of CD52 in peripheral T-cell lymphoma. Haematologica 92 (2007) 566-567
23. Tan B.T., Warnke R.A., and Arber D.A. The frequency of B- and T-cell gene rearrangements and Epstein-Barr virus in T-cell lymphomas: a comparison between angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified with and without associated B-cell proliferations. J Mol Diagn 8 (2006) 466-475
24. Kaneko Y., Maseki N., Sakurai M., et al. Characteristic karyotypic pattern in T-cell lymphoproliferative disorders with reactive "angioimmunoblastic lymphadenopathy with dysproteinemia-type" features. Blood 72 (1988) 413-421
25. Willenbrock K., Roers A., Seidl C., et al. Analysis of T-cell subpopulations in T-cell non-Hodgkin's lymphoma of angioimmunoblastic lymphadenopathy with dysproteinemia type by single target gene amplification of T cell receptor-beta gene rearrangements. Am J Pathol 158 (2001) 1851-1857
26. Willenbrock K., Renne C., Gaulard P., and Hansmann M.L. In angioimmunoblastic T-cell lymphoma, neoplastic T cells may be a minor cell population. A molecular single-cell and immunohistochemical study. Virchows Arch 446 (2005) 15-20
27. Smith J.L., Hodges E., Quin C.T., McCarthy K.P., and Wright D.H. Frequent T and B cell oligoclones in histologically and immunophenotypically characterized angioimmunoblastic lymphadenopathy. Am J Pathol 156 (2000) 661-669
28. Anagnostopoulos I., Hummel M., Finn T., et al. Heterogeneous Epstein-Barr virus infection patterns in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type. Blood 80 (1992) 1804-1812
29. Schlegelberger B., Feller A., Himmler A., and Grote W. Inv(14)(q11q32) in one of four different clones in a case of angioimmunoblastic lymphadenopathy. Cancer Genet Cytogenet 44 (1990) 77-81
30. Schlegelberger B., Nolle I., Feller A.C., Bauer E., and Grote W. Angioimmunoblastic lymphadenopathy with trisomy 3: the cells of the malignant clone are T cells. Hematol Pathol 4 (1990) 179-183
31. Schlegelberger B., Zwingers T., Hohenadel K., et al. Significance of cytogenetic findings for the clinical outcome in patients with T-cell lymphoma of angioimmunoblastic lymphadenopathy type [see comments]. J Clin Oncol 14 (1996) 593-599
32. de Leval L., Rickman D.S., Thielen C., et al. The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells. Blood 109 (2007) 4952-4963
33. Piccaluga P.P., Agostinelli C., Califano A., et al. Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation. Cancer Res 67 (2007) 10703-10710
34. Frizzera G., Moran E.M., and Rappaport H. Angio-immunoblastic lymphadenopathy with dysproteinaemia. Lancet 1 (1974) 1070-1073
35. Siegert W., Nerl C., Agthe A., et al. Angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma: prognostic impact of clinical observations and laboratory findings at presentation. The Kiel Lymphoma Study Group. Ann Oncol 6 (1995) 659-664
36. Jaffe E.S. Angioimmunoblastic T-cell lymphoma: new insights, but the clinical challenge remains [editorial]. Ann Oncol 6 (1995) 631-632
37. Yuan C.M., Vergilio J.A., Zhao X.F., et al. CD10 and BCL6 expression in the diagnosis of angioimmunoblastic T-cell lymphoma: utility of detecting CD10+ T cells by flow cytometry. Hum Pathol 36 (2005) 784-791
38. Abruzzo L.V., Schmidt K., Weiss L.M., et al. B-cell lymphoma after angioimmunoblastic lymphadenopathy: a case with oligoclonal gene rearrangements associated with Epstein-Barr virus. Blood 82 (1993) 241-246
39. Nathwani B.N., Rappaport H., Moran E.M., Pangalis G.A., and Kim H. Malignant lymphoma arising in angioimmunoblastic lymphadenopathy. Cancer 41 (1978) 578-606
40. Quintini G., Iannitto E., Barbera V., et al. Response to low-dose oral methotrexate and prednisone in two patients with angio-immunoblastic lymphadenopathy-type T-cell lymphoma. Hematol J 2 (2001) 393-395
41. Ong S.T., Koeppen H., Larson R.A., and Olopade O.I. Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia with fludarabine. Blood 88 (1996) 2354-2355
42. Tsatalas C., Margaritis D., Kaloutsi V., et al. Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia-type T-cell lymphoma with fludarabine. Acta Haematol 105 (2001) 106-108
43. Sallah A.S., and Bernard S. Treatment of angioimmunoblastic lymphadenopathy with dysproteinemia using 2-chlorodeoxyadenosine. Ann Hematol 73 (1996) 295-296
44. Hast R., Jacobsson B., Petrescu A., and Hjalmar V. Successful treatment with fludarabine in two cases of angioimmunoblastic lymphadenopathy with dysproteinemia. Leuk Lymphoma 34 (1999) 597-601
45. Advani R., Warnke R., Sikic B.I., and Horning S. Treatment of angioimmunoblastic T-cell lymphoma with cyclosporine. Ann Oncol 8 (1997) 601-603
46. Takemori N., Kodaira J., Toyoshima N., et al. Successful treatment of immunoblastic lymphadenopathy-like T-cell lymphoma with cyclosporin A. Leuk Lymphoma 35 (1999) 389-395
47. Dogan A., Ngu L.S., Ng S.H., and Cervi P.L. Pathology and clinical features of angioimmunoblastic T-cell lymphoma after successful treatment with thalidomide. Leukemia 19 (2005) 873-875
48. Pautier P., Devidas A., Delmer A., et al. Angioimmunoblastic-like T-cell non Hodgkin's lymphoma: outcome after chemotherapy in 33 patients and review of the literature. Leuk Lymphoma 32 (1999) 545-552
49. Lee S.S., Rudiger T., Odenwald T., et al. Angioimmunoblastic T cell lymphoma is derived from mature T-helper cells with varying expression and loss of detectable CD4. Int J Cancer 103 (2003) 12-20
50. Rudiger T., Weisenburger D.D., Anderson J.R., et al. Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project. Ann Oncol 13 (2002) 140-149
51. Gallamini A., Stelitano C., Calvi R., et al. Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study. Blood 103 (2004) 2474-2479
52. Zhao W.L., Mourah S., Mounier N., et al. Vascular endothelial growth factor-A is expressed both on lymphoma cells and endothelial cells in angioimmunoblastic T-cell lymphoma and related to lymphoma progression. Lab Invest 84 (2004) 1512-1519
53. Siegert W., Agthe A., Griesser H., et al. Treatment of angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma using prednisone with or without the COPBLAM/IMVP-16 regimen. A multicenter study. Kiel Lymphoma Study Group. Ann Intern Med 117 (1992) 364-370
54. Schetelig J., Fetscher S., Reichle A., et al. Long-term disease-free survival in patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation. Haematologica 88 (2003) 1272-1278
55. Siegert W., Nerl C., Meuthen I., et al. Recombinant human interferon-alpha in the treatment of angioimmunoblastic lymphadenopathy: results in 12 patients. Leukemia 5 (1991) 892-895
56. Strupp C., Aivado M., Germing U., Gattermann N., and Haas R. Angioimmunoblastic lymphadenopathy (AILD) may respond to thalidomide treatment: two case reports. Leuk Lymphoma 43 (2002) 133-137
57. Gallamini A., Zaja F., Patti C., et al. Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL prospective multicentre trial. Blood 110 (2007) 2316-2323